Correction to: Gene Therapy advance online publication 14 January 2016; doi:10.1038/gt.2015.110
Following the online publication for this article, the authors noted that the funding information provided was incomplete. The full correct funding statement should appear as follows:
Funded by ViroMed Co., Ltd, Seoul, Korea, and Reyon Pharmaceutical Co., Ltd, Seoul Korea, and supported by the Industrial Strategic Technology Development Program (grant no. 10031644, ‘Clinical development of cardiovascular therapeutics (VM202) using novel hepatocyte growth factor gene in the US’) funded by the Ministry of Trade, Industry & Energy (MI, Korea).
Additional information
The online version of the original article can be found at 10.1038/gt.2015.110
Rights and permissions
About this article
Cite this article
Kibbe, M., Hirsch, A., Mendelsohn, F. et al. Erratum: Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene Ther 23, 399 (2016). https://doi.org/10.1038/gt.2016.9
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2016.9
